Skin Bliss Mist

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the management of acne. It is specifically formulated to address the symptoms and underlying causes associated with this condition.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

The product is to be administered twice to three times daily. It should be applied on a clean, dry face by spraying the product from a distance of 4 to 6 inches away from the skin. Alternatively, the product may be sprayed into the hands and then applied to the face.

A thin layer of the product should be evenly distributed to cover the entire face, taking care to avoid contact with the eyes. After application, the product should be gently rubbed into the skin using clean hands. It is essential to allow the product to dry completely before applying any other skincare products.

Contraindications

Use is contraindicated in the following situations:

• The product should be kept out of reach of children to prevent accidental ingestion.

• In the event of accidental swallowing, immediate medical assistance or contact with a poison control center is required.

• Discontinue use and consult a healthcare professional if skin irritation develops or worsens.

• Avoid contact with eyes; if contact occurs, rinse thoroughly with water.

Warnings and Precautions

For external use only. It is imperative that this product is kept out of reach of children to prevent accidental ingestion. In the event of swallowing, immediate medical assistance should be sought, or contact a poison control center without delay.

Healthcare professionals should advise patients to discontinue use and consult a physician if any skin irritation occurs or worsens during treatment. Prompt medical attention is essential if the product is ingested, reinforcing the need for vigilance in monitoring for adverse reactions.

Side Effects

Patients should be aware that the product is for external use only. Adverse reactions associated with the use of this product may vary in severity and frequency.

In clinical trials, participants reported a range of adverse reactions, although specific data on the frequency and seriousness of these reactions were not provided. Postmarketing experiences may also reveal additional adverse reactions that were not observed during clinical trials.

Healthcare professionals are encouraged to monitor patients for any unexpected reactions and report them accordingly.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Skin Bliss Mist (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a poison control center is recommended.

Geriatric Use

There is no specific information regarding the use of Skin Bliss Mist (salicylic acid spray) in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this medication to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment outcomes in this population.

Pregnancy

There is no information available regarding the use of Skin Bliss Mist (salicylic acid spray) during pregnancy. The drug insert does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when considering the use of this product in women of childbearing potential and weigh the potential risks and benefits. It is advisable to discuss any concerns with patients and consider alternative treatments that have established safety profiles during pregnancy.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific information is available.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, including airway management, oxygen supplementation, and intravenous fluids.

If the specific agent involved in the overdose is known, appropriate antidotes or treatments should be administered as per established guidelines. Continuous monitoring of the patient is crucial to identify any evolving symptoms and to adjust management strategies accordingly.

In all cases of suspected overdose, it is advisable to contact a poison control center or consult relevant toxicology resources for guidance on management and treatment protocols.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should seek medical help or contact a poison control center immediately.

Patients should be informed to discontinue use and consult a doctor if they experience skin irritation that occurs or worsens during treatment. It is important to note that skin irritation and dryness may be more pronounced if patients are using another topical acne medication concurrently. Therefore, healthcare providers should recommend that patients use only one topical acne medication at a time to minimize the risk of irritation.

Additionally, patients should be cautioned to avoid contact with the eyes. In the case of accidental contact, they should flush the eyes thoroughly with water and seek medical attention if irritation persists.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity.

To ensure optimal preservation, the product must be protected from light exposure. Additionally, it is crucial to keep the container tightly closed when not in use to prevent contamination and degradation.

If the product is not utilized within a specified time frame after opening, it should be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is intended for application twice to three times daily on a clean, dry face. It should be sprayed from a distance of 4 to 6 inches from the skin, or alternatively, sprayed into the hands and then applied to the face. Clinicians should advise patients to cover the entire face with a thin layer of the product while avoiding the eyes. After application, patients should use clean hands to rub the product into the skin and allow it to dry completely before applying any other products.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Skin Bliss Mist, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)